# Oral Mini Pulse Dexamethasone in Pediatric Vitiligo

> **NCT07353801** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Cairo University** · enrollment: 22 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** Dexamethasone (0.1 mg/kg)

## Key facts

- **NCT ID:** NCT07353801
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-02-28
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07353801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07353801, "Oral Mini Pulse Dexamethasone in Pediatric Vitiligo". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07353801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*